FDA
-
-
-
-
-
-
-
Medolife Rx Announces that the Government of the Dominican Republic is Willing to Include Escozine into its COVID-19 Treatment Regimen
-
-
-
-
-
-
-
Medolife Rx Clinical Observations Demonstrates Effectiveness of Escozine in Complementary Use with COVID-19 Vaccines
-
-
-
-
-
-
-
Medolife Rx Reports First Quarter 2021 Financial and Operational Results, Schedules Conference Call with Investment Community
-
-
-
-
-
-
-
Medolife Rx (Quanta, Inc.) Reports Over $1 Million in Revenue in 2020 Year-End Filing, Comments on Operations
-
-
-
-
-
-
-
Medolife Rx Announces Positive Results in Clinical Safety Study on Its Polarized Drug Candidate for the Treatment of COVID-19
-
-
-
-
-
251,895 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All